Cellectis SA (NAS:CLLS)
$ 1.56 0 (0%) Market Cap: 154.13 Mil Enterprise Value: -15.24 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 70/100

Cellectis SA at JMP Securities Life Sciences Conference Transcript

Jun 16, 2022 / 02:00PM GMT
Release Date Price: $2.39 (-4.40%)
Silvan Türkcan
JMP Securities LLC - Analyst

Welcome back to the JMP Life Sciences Conference, the second day. My name is Silvan Türkcan. I'm a senior analyst covering precision medicines here. It's my pleasure to host Cellectis at today's conference. André Choulika, CEO and Founder; and Arthur Stril, Chief Business Officer. Thank you. Thanks for joining us today.

AndrÃ;Choulika
Cellectis SA - CEO & Board Director

© -

Thanks for inviting us.

Arthur Stril
Cellectis SA - Chief Business Officer

Thanks for inviting us.

Questions & Answers

Silvan Türkcan;AndrÃ;Choulika
JMP Securities LLC - Analyst;Cellectis SA - CEO & Board Director<

So, obviously, maybe we could start with your view about the allogeneic CAR T space coming out of all the data sets that we've seen at ACR, EHA, ASCO. The recent days, there have been a lot of updates. So can you just tell us how -- where are we now with ALLO?

©

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot